Mark Davis

Mark Davis is an accomplished professional in the field of chemistry, currently serving as the Director of Analytical Chemistry at Flare Therapeutics since April 2023. Prior experience includes significant roles at Gilead Sciences, where Mark managed multiple projects in various stages of development as a Senior Research Scientist II/Associate Director and supported the commercialization of APIs as a Research Scientist II. At Virginia Commonwealth University, Mark contributed as a Teaching Assistant and completed a Ph.D. in organic/analytical chemistry. Mark's earlier career at Boehringer Ingelheim Chemicals involved extensive responsibilities as a Senior Scientist and Senior Analytical Chemist, focusing on improving product quality and ensuring compliance with cGMP guidelines. Mark holds a Bachelor of Science in Chemistry and Biology from Heidelberg University.